LeroyDumonde
Platinum Member
- May 30, 2023
- 4,543
- 2,944
- 938
The two studies measured different things. The study you cite measured viral clearing rate. The study I cited measured death rates. My study had 3406 subjects. Yours had only 205. Your study was funded by a grant from the Wellcome Trust. This trust is designed to give grant money to people within their first 3 years of their first permanent position. That means that the researchers are relatively inexperienced.I'll see your 2 year old article that says Ivermectin "may" help with covid; and raise you a current article that says it doesn't...
![]()
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) - PubMed
NCT05041907.pubmed.ncbi.nlm.nih.gov
Conclusions: High-dose ivermectin did not have measurable antiviral activity in early symptomatic COVID-19.